BACKGROUND: As neoadjuvant chemotherapy (NAC) is increasingly used to downstage
patients with breast cancer, the timing of the sentinel node (SN) biopsy has become an …

The past few decades have seen an increase in both the role and the complexity of
neoadjuvant therapy for breast cancer. Neoadjuvant therapy was initially described as …

PURPOSE To provide recommendations on the best strategies for the management and on
the best timing and treatment (surgical and radiotherapeutic) of the axilla for patients with …

Purpose An increasing proportion of patients (> 30%) with node-positive breast cancer will
obtain an axillary pathologic complete response after neoadjuvant chemotherapy (NAC). If …

Background In sentinel node surgery for breast cancer, procedural accuracy is assessed by
calculating the false-negative rate. It is important to measure this since there are potential …

Background With the increased use of neoadjuvant chemotherapy (NAC) in breast cancer,
the timing of sentinel lymph node biopsy (SLNB) has become increasingly important. In this …

Background: Neoadjuvant chemotherapy (NAC) is increasingly used to treat patients with
breast cancer, but the reliability of sentinel lymph node biopsy (SLNB) following …

Abstract Preoperative (neoadjuvant) chemotherapy (NC) has become the standard of care
for patients with locally advanced breast cancer and is being increasingly used in those with …

Background Axillary surgery after neoadjuvant chemotherapy (NAC) is becoming less
extensive. We evaluated the evolution of axillary surgery after NAC on the multi-institutional I …

The optimal method for locoregional staging in patients treated with neoadjuvant
chemotherapy (NAC), usually ultrasound (US) and pre-or post-chemotherapy sentinel lymph …